This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P160002S008 |
Classification Name | None |
Applicant | |
PMA | P160002 |
Supplement | S008 |
Supplement Number | Date | Supplement Type |
---|---|---|
P160002 | Original Filing | |
S019 | 2022-10-14 | 30-day Notice |
S018 | 2022-07-12 | 30-day Notice |
S017 | 2022-02-16 | Special (immediate Track) |
S016 | 2022-01-28 | 135 Review Track For 30-day Notice |
S015 | 2021-09-07 | Special (immediate Track) |
S014 | 2021-02-22 | Real-time Process |
S013 | 2020-08-26 | Real-time Process |
S012 | 2020-01-21 | Normal 180 Day Track |
S011 | 2020-01-13 | Real-time Process |
S010 | 2019-08-22 | Real-time Process |
S009 | 2018-09-14 | Panel Track |
S008 | ||
S007 | 2018-06-18 | Real-time Process |
S006 | 2018-06-14 | Normal 180 Day Track |
S005 | ||
S004 | ||
S003 | 2017-07-17 | 30-day Notice |
S002 | 2017-03-16 | Normal 180 Day Track No User Fee |
S001 | 2016-09-01 | Normal 180 Day Track No User Fee |